 stabil fundament
expect skew risk/reward upgrad buy
messag share dramat under-perform market
past year vs owe combin poor
fundament disappoint capit alloc strategi recent guid
consensu believ somewhat conserv may serv
clear event share appreci linger concern around medic
busi opioid litig address believ share offer much
valu ignor upgrad buy new pt assum
share trade would still repres slight discount averag
suppli chain peer discount averag
bottom line perform capit deploy strategi much past
decad larg disappoint said believ risk/reward
share start skew favor see multipl way sharehold benefit
go forward current valuat expect level first see greenshoot
stabil medic segment may
lost investor amidst cloud disappoint guidanc view guidanc
reason potenti upsid current environ particularli
shareholder-friendli capit deploy strategi secondli believ investor patienc
worn thin event result improv manag team board
may soon start consid restructur altern obviou one
separ two divis spin medic segment lastli appreci
opioid overhang signific believ meaning settlement would take place
mani year enabl compani manag outcom free cash
flow balanc sheet capac would also suggest reason settlement
would serv posit catalyst share
segment share challeng start
greenshoot stabil coupl reason guidanc clear
believ compani fundament great believ start see
sign stabil also believ compani initi ep guidanc
conserv assum signific oper profit contract pharmaceut
segment low double-digit op profit expans medic slightli exclud impact
charg discuss believ guidanc reason
serv base-level expect investor highlight detail
segment
pharmaceut segment note big three custom renew optum
kr repres revenu lock next four year compani
acknowledg gener deflat moder brand inflat seem stabl
competit environ feel somewhat ration less contract churn industri top
line growth remain adequ specialti continu grow nice acknowledg
opioid litig concern remain front center address detail
think particular consid may benefit favor
gener deflat environ well signific level cost save
total would repres tailwind segment
give us comfort around guidanc hsd-ldd oper profit declin
medic segment would suggest bulk cordi infrastructur invest seem
behind compani oper issu plagu patient recoveri busi
control current annual oper profit level estim
offer signific cash flow futur invest growth estim growth
segment would slightli exclud estim charg taken
think particular note benefit lap charg
well signific level cost save total
page analyst certif import disclosur
would repres tailwind medic segment give us comfort
around guidanc ldd growth
split compani medic could put
independ compani better respect path unlock sharehold valu
sotp analysi divis challeng fundament path
stabl result seem obviou side busi
problem medic divis opaqu seemingli outsid manag
core area expertis recal manag team larg inherit current strategi
believ compani ultim sharehold could benefit split two
divis allow manag financ separ entiti sotp
analysi assum ev/ebitda multipl pharmaceut segment
discount averag closest peer pt would impli ev/
ebitda multipl cah medic segment would suggest compar favor
rel smid cap medic technolog peer trade north averag
see bodi note
contrari convent wisdom believ balanc sheet leverag somewhat
insul compani respect opioid litig dont realli great
sens litig ultim play wholesal acknowledg
probabl degre neglig industri part ultim
track toward sort settlement admit hard estim fine/settl
precis oddli take comfort fact cah balanc sheet
alreadi lever believ court regulatori bodi go take suppli
chain integr seriou consider levi and/or structur settlement
ebitda roughli half amount compani could
easili digest full turn leverag minim disrupt settlement
spread year expect case settlement number
could toler would obvious greater estim increment
debt would repres annual adjust ep headwind
yield dividend provid downsid support current
estim roughli addit current dividend yield
make one highest dividend-yield stock health care servic
believ solid cash flow dividend offer investor downsid protect
valuat share current trade estim ebitda
repres roughli discount compani two closest peer well
compani histor averag acknowledg discount
peer cah histor averag warrant owe disappoint fundament
gener lack visibl medic segment howev upgrad buy
neutral believ narrow discount make sens industri
alreadi trade histor averag upgrad share rais
pt assum roughli ev/ebitda multipl
page analyst certif import disclosur
background compani decis grow medic struggl start august georg barrett appoint
chairman ceo cardin two month post appoint compani complet previous plan spin-off
carefus collect medic technolog busi compani revisit strategi get back medic
technolog busi logic time vertic integr upstream higher margin proprietari medic technolog
busi could augment compani exist med/surg distribut busi compani spent close
medic technolog acquisit compar current total market cap result segment
disappoint manag repeatedli defend strategi despit inconsist result contract
believ opportun underachiev un-lev stand-alon compani
believ opportun under-perform medic technolog asset marketplac investor seen playbook
struggl medic technolog asset abl bolster manag focu oper posit asset
self-help stori use cash flow asset acquir addit busi strengthen broader portfolio
last decad sever similar situat come mind cardin spin carefus legaci halyard health
asset went seri acquisit divestitur fulli appreci signific differ cardin
current medic segment compani mention obviou differ commodit natur cah
current product portfolio said suggest situat somewhat analog compani underw
type restructur initi ultim abl improv oper respect portfolio
current estim medic technolog segment gener revenu approxim oper profit
believ separ medic segment could unlock valu compani abl manag cash
flow capit alloc individu basi base analysi medic technolog compani similar situat
medic busi ran independ would like three main area focu capit alloc improv oper
expand portfolio busi implement chang time believ medic busi
could earn ebitda multipl current moreov without medic overhang valuat gap cardin
busi distribut peer narrow although acknowledg element cah
busi riskier peer notabl leverag sotp analysi assign ev/ebitda multipl
pharmaceut segment discount averag closest peer pt would impli ev/ebitda multipl
medic segment would suggest compar favor smid cap medic technolog peer trade north
averag
figur part analysi
page analyst certif import disclosur
quantifi impact potenti settlement
compani file factset guggenheim secur llc estim
mention previous dont great sens pend litig ultim play wholesal
admittedli struggl frame potenti settlement scenario acknowledg probabl degre neglig
industri part ultim track toward sort settlement admit hard estim fine/settl
precis oddli take comfort fact cah balanc sheet alreadi lever believ court regulatori
bodi go take suppli chain integr seriou consider levi and/or structur settlement almost
adjust ebitda healthi profil believ posit digest sizabl fine minim disrupt
think potenti outcom refer recent bloomberg report suggest distributor collect offer pay
fine nation associ attorney gener suggest fine gener rang mind consid
follow outcom fine year midpoint would repres fine
paid year year believ could larg pay current dividend fine annual current free
cash flow estim put addit leverag perspect increment debt would repres
headwind annual adjust ep base interest rate current share count
figur annual opioid fine million
estim chang adjust revenue/adjust ebitda estim
 previous
share current trade estim ebitda repres roughli discount compani
two closest peer well compani histor averag acknowledg discount peer
cah histor averag warrant owe disappoint fundament gener lack visibl medic segment
howev upgrad buy believ narrow discount make sens industri alreadi trade
histor averag upgrad share rais pt assum roughli ev/ebitda
multipl risk downsid potenti less favor brand gener price addit on-going opioid
litig continu risk downsid potenti magnitud time fine unknown
page analyst certif import disclosur
